ABEO vs ALB · rev $20.1M vs rev $1.74B
Abeona Therapeutics Inc (ABEO) versus Albemarle Corp (ALB) — a side-by-side from cached financials, not a winner call.
Abeona Therapeutics Inc (ABEO) is a biotechnology company listed on US.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Latest reported ABEO revenue for 2026-06-30 was $20.1M. Net income was -$37.3M. ABEO currently screens at market cap $301.8M.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
ABEO currently screens at market cap $301.8M. ALB currently screens at market cap $8.00B.
Not investment advice. Open the ABEO and ALB stock pages for the full models.
Not investment advice.